Skip to main content
. 2020 Feb 12;95(2):165–172. doi: 10.1016/j.abd.2019.07.006

Table 4.

The rates of metabolic syndrome between the study and control groups after the exclusion of the patients with obesity, diabetes mellitus, Hashimoto’s thyroiditis, vitamin B12 deficiency and alcohol consumption according to both NCEP-ATPIII and IDF criteria

Group NCEP-ATPIII metabolic syndrome positive IDF metabolic syndrome positive p-Value
Study Group, n (%) 34/86 (39.5%) 35/86 (40.7%) <0.001
Control Group, n (%) 10/115 (8.7%) 18/115 (15.6%) <0.001

NCEP-ATPIII, National Cholesterol Education Program Adult Treatment Panel III; IDF, The International Diabetes Federation.